Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Working Capital to Net Assets Ratio
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Working Capital to Net Assets ratio of 909.4% as of June 2026. Working capital of $1.06 Billion (current assets of $1.95 Billion minus current liabilities of $883.19 Million) is measured against net assets of $116.98 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Amneal Pharmaceuticals, Inc. Class A Common Stock Working Capital to Net Assets (2015–2025)
This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 909.4%, reflecting working capital of $1.06 Billion against net assets of $116.98 Million USD. Explore Amneal Pharmaceuticals, Inc. Class A Com strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AMRX total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17265.6% | $1.03 Billion | $5.96 Million | $1.91 Billion | $881.63 Million | ▲ +18294.0 pp |
| 2024 | -1028.4% | $458.04 Million | $-44.54 Million | $1.59 Billion | $1.13 Billion | ▼ -1895.0 pp |
| 2023 | 866.6% | $531.27 Million | $61.30 Million | $1.38 Billion | $846.60 Million | ▲ +551.2 pp |
| 2022 | 315.4% | $659.02 Million | $208.93 Million | $1.41 Billion | $752.80 Million | ▲ +85.7 pp |
| 2021 | 229.7% | $842.87 Million | $366.97 Million | $1.52 Billion | $677.24 Million | ▼ -15.5 pp |
| 2020 | 245.2% | $874.64 Million | $356.74 Million | $1.55 Billion | $676.90 Million | ▲ +54.9 pp |
| 2019 | 190.3% | $659.80 Million | $346.79 Million | $1.21 Billion | $550.41 Million | ▲ +108.5 pp |
| 2018 | 81.8% | $732.79 Million | $896.36 Million | $1.29 Billion | $553.85 Million | ▲ +208.2 pp |
| 2017 | -126.5% | $475.05 Million | $-375.58 Million | $771.93 Million | $296.88 Million | ▲ +158.3 pp |
| 2016 | -284.8% | $501.04 Million | $-175.94 Million | $726.11 Million | $225.07 Million | ▼ -89.2 pp |
| 2015 | -195.6% | $365.45 Million | $-186.87 Million | $604.60 Million | $239.15 Million | — |